Therapies in early development for the treatment of urinary tract inflammation
- 22 March 2016
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Investigational Drugs
- Vol. 25 (5) , 531-540
Abstract
Introduction: Urinary tract inflammation is a very common clinical condition. It is caused by several pathogens and antibiotic treatment is the mainstay of therapy. Increasing antimicrobial resistance and high recurrence rates represent a challenge. Consequently, there is an unmet need for new therapeutic options.Areas covered: The authors discuss the rationale of emerging management strategies and current experimentation. Furthermore, they focus on both acute and recurrent urinary tract infections (UTIs) and examine a range of therapeutics, including new antibiotics, vaccines, mannosides, hyaluronic acid, probiotics, immunomodulant agents and novel compounds derived from nanotechnology.Expert opinion: Basic science studies have elucidated the pathogenesis of UTIs and built up the ground for the development of new therapies. Evidence is mainly derived from animal studies on murine models of bacterial cystitis. However, clinical trials are scanty and cannot provide us with robust evidence. Hetereog...Keywords
This publication has 117 references indexed in Scilit:
- Merging mythology and morphology: the multifaceted lifestyle of Proteus mirabilisNature Reviews Microbiology, 2012
- Host–pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenicEscherichia colibladder infectionFEMS Microbiology Reviews, 2012
- Activity of finafloxacin, a novel fluoroquinolone with increased activity at acid pH, towards extracellular and intracellular Staphylococcus aureus, Listeria monocytogenes and Legionella pneumophilaInternational Journal of Antimicrobial Agents, 2011
- Randomized, Placebo-Controlled Phase 2 Trial of a Lactobacillus crispatus Probiotic Given Intravaginally for Prevention of Recurrent Urinary Tract InfectionClinical Infectious Diseases, 2011
- Positive selection identifies an in vivo role for FimH during urinary tract infection in addition to mannose bindingProceedings of the National Academy of Sciences, 2009
- Iron in innate immunity: starve the invadersCurrent Opinion in Immunology, 2009
- Iron Homeostasis: Recently Identified Proteins Provide Insight into Novel Control MechanismsJournal of Biological Chemistry, 2009
- Community-onset Urinary Tract Infections: A Population-based AssessmentInfection, 2007
- Bioactive compounds in cranberries and their role in prevention of urinary tract infectionsMolecular Nutrition & Food Research, 2007
- Effect of antimicrobial agents on the ecological balance of human microfloraThe Lancet Infectious Diseases, 2001